Helmholtz Gemeinschaft


Cardiometabolic HFpEF: mechanisms and therapies

PDF (Original Article) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader

Item Type:Review
Title:Cardiometabolic HFpEF: mechanisms and therapies
Creators Name:Schiattarella, G.G. and Hill, J.A.
Abstract:Heart failure with preserved ejection fraction (HFpEF) accounts for at least half of all patients with heart failure (HF) and is projected to be the most common form of HF in the near feature. HFpEF, characterized by high morbidity and mortality, poses an enormous medical and societal burden and lacks evidence-based therapies. Hence, HFpEF has been recognized as the greatest unmet need in cardiovascular medicine. HFpEF is a heterogenous syndrome presenting as several different clinical phenotypes. Among these, metabolic alteration-driven HFpEF - i.e. cardiometabolic HFpEF - is emerging around the globe as the most prevalent form of HFpEF. Pathophysiological mechanisms of cardiometabolic HFpEF are still incompletely understood. However, recent advances in the preclinical modeling of the syndrome, coupled with better definition of its clinical presentations and analysis of human HFpEF myocardial specimens, have unveiled metabolic disturbances and inflammatory burden as 2 key drivers of HFpEF pathophysiology. Here, we summarize evidence in support of a cardiometabolic phenotype of HFpEF and discuss the pivotal biological mechanisms underlying this syndrome in the hope of informing more efficacious therapeutic approaches in the future.
Keywords:Heart Failure, Cardiometabolic Syndrome, Molecular Biology, Obesity, Inflammation
Source:CardioMetabolic Syndrome Journal
Publisher:Korean Society of CardioMetabolic Syndrome
Page Range:117-124
Date:September 2021
Official Publication:https://doi.org/10.51789/cmsj.2021.1.e18

Repository Staff Only: item control page


Downloads per month over past year

Open Access
MDC Library